BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ishikawa T. Future perspectives on the treatment of hepatocellular carcinoma with cisplatin. World J Hepatol 2009; 1(1): 8-16 [PMID: 21160960 DOI: 10.4254/wjh.v1.i1.8]
URL: https://www.wjgnet.com/1948-5182/full/v1/i1/8.htm
Number Citing Articles
1
Toru Ishikawa. Treatment Strategy for Recurrent Multiple Hepatocellular CarcinomaJournal of Cancer Therapy 2013; 4(02): 408 doi: 10.4236/jct.2013.42A049
2
Eucalyptol Protects against Cisplatin-Induced Liver Injury in RatsBiology Bulletin 2023; 50(5): 987 doi: 10.1134/S106235902360085X
3
Jean-Philippe Guégan, Frédéric Ezan, Nathalie Théret, Sophie Langouët, Georges Baffet. MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cellsCarcinogenesis 2013; 34(1): 38 doi: 10.1093/carcin/bgs317
4
Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita, Toru Kimura. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in JapanCancers 2012; 4(1): 165 doi: 10.3390/cancers4010165
5
HIROKI NISHIKAWA, YUKIO OSAKI, ERIKO IGUCHI, HARUHIKO TAKEDA, JUN NAKAJIMA, FUMIHIRO MATSUDA, AZUSA SAKAMOTO, SHINICHIRO HENMI, KEIICHI HATAMARU, SUMIO SAITO, AKIHIRO NASU, RYUICHI KITA, TORU KIMURA. Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinomaExperimental and Therapeutic Medicine 2012; 4(3): 381 doi: 10.3892/etm.2012.611
6
Wei Wang, Jianwen Cheng, Jiang-Jiang Qin, Sukesh Voruganti, Subhasree Nag, Jia Fan, Qiang Gao, Ruiwen Zhang. RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivoOncotarget 2014; 5(22): 11604 doi: 10.18632/oncotarget.2598
7
Mayada M. El-Gizawy, Eman N. Hosny, Hagar H. Mourad, Amira N. Abd-El Razik. Curcumin nanoparticles ameliorate hepatotoxicity and nephrotoxicity induced by cisplatin in ratsNaunyn-Schmiedeberg's Archives of Pharmacology 2020; 393(10): 1941 doi: 10.1007/s00210-020-01888-0
8
Aleyna Atik, Tuğçe Günal, Pınar Acar Bozkurt, Sıla Naz Köse, Burcak Alp, Cihangir Yandım, Nurettin Mete Kaleli, Gözde Kabay, Gizem Kaleli-Can. Characterization of cisplatin loaded hydrophilic glycol chitosan modified eumelanin nanoparticles for potential controlled-release applicationJournal of Drug Delivery Science and Technology 2023; 84: 104440 doi: 10.1016/j.jddst.2023.104440
9
Enas Tahoun, Gamalat Elgedawy, Amanallah El-Bahrawy. Cytoprotective effect of ginger extract on cisplatin-induced hepatorenal toxicity in rats via modulation of oxidative stress, inflammation and apoptosis: histopathological, biochemical and immunohistochemical studyComparative Clinical Pathology 2021; 30(4): 647 doi: 10.1007/s00580-021-03256-7
10
Alina-Veronica Ghionescu, Andrei Sorop, Simona Olimpia Dima. The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinomaFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1270425
11
Kohei Ogawa, Kenya Kamimura, Yukari Watanabe, Yosuke Motai, Daisuke Kumaki, Ryoya Seki, Akira Sakamaki, Satoshi Abe, Hirokazu Kawai, Takeshi Suda, Satoshi Yamagiwa, Shuji Terai. Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two casesWorld Journal of Clinical Cases 2017; 5(6): 238-246 doi: 10.12998/wjcc.v5.i6.238
12
Masafumi Ikeda, Takuji Okusaka, Yozo Sato, Junji Furuse, Shuichi Mitsunaga, Hideki Ueno, Chigusa Morizane, Yoshitaka Inaba, Tatsushi Kobayashi, Yasuaki Arai. A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinomaJapanese Journal of Clinical Oncology 2017; 47(6): 512 doi: 10.1093/jjco/hyx038
13
Cheng-Jeng Tai, Wen-Ching Wang, Chien-Kai Wang, Chih-Hsiung Wu, Mei-Due Yang, Yu-Jia Chang, Jiun-Yu Jian, Chen-Jei Tai. Fermented Wheat Germ Extract Induced Cell Death and Enhanced Cytotoxicity of Cisplatin and 5-Fluorouracil on Human Hepatocellular Carcinoma CellsEvidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/121725
14
Koichi Hamada, Shigeki Imai, Satoshi Saitoh. Safety and efficacy of transcatheter arterial chemoembolization using miriplatin and cisplatin (double platinum-lipiodol suspension) for hepatocellular carcinomaKanzo 2014; 55(3): 189 doi: 10.2957/kanzo.55.189
15
Mahendra Pal Singh, Hee Jun Cho, Jong-Tae Kim, Kyoung Eun Baek, Hee Gu Lee, Sun Chul Kang. Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular CarcinomaCancers 2019; 11(7): 986 doi: 10.3390/cancers11070986
16
Dan Li, Xuefeng Liu, Jian Zhou, Jie Hu, Dongdong Zhang, Jing Liu, Yanyan Qiao, Qimin Zhan. Long noncoding RNA HULC modulates the phosphorylation of YB‐1 through serving as a scaffold of extracellular signal–regulated kinase and YB‐1 to enhance hepatocarcinogenesisHepatology 2017; 65(5): 1612 doi: 10.1002/hep.29010
17
Jesmin Mondal, Anisur Rahman Khuda-Bukhsh. Cisplatin and farnesol co-encapsulated PLGA nano-particles demonstrate enhanced anti-cancer potential against hepatocellular carcinoma cells in vitroMolecular Biology Reports 2020; 47(5): 3615 doi: 10.1007/s11033-020-05455-x
18
Jun Gao, Chao Dai, Xin Yu, Xiang‐Bao Yin, Fan Zhou. Long noncoding RNA LEF1‐AS1 acts as a microRNA‐10a‐5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathwayJournal of Cellular Biochemistry 2021; 122(1): 86 doi: 10.1002/jcb.29833
19
Moumita Maji, Indira Bhattacharya, Sourav Acharya, Manas Pratim Chakraborty, Arnab Gupta, Arindam Mukherjee. Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer CellsInorganic Chemistry 2021; 60(7): 4342 doi: 10.1021/acs.inorgchem.0c03803
20
HIROKI NISHIKAWA, YUKIO OSAKI, RYUICHI KITA, TORU KIMURA, YOSHIAKI OHARA, HARUHIKO TAKEDA, AZUSA SAKAMOTO, SUMIO SAITO, NORIHIRO NISHIJIMA, AKIHIRO NASU, HIDEYUKI KOMEKADO, SHUHEI NISHIGUCHI. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinomaOncology Reports 2014; 31(1): 65 doi: 10.3892/or.2013.2845
21
Shogo Ohkoshi. Interferon- β Augments the Effects of Cisplatin on Hcc Cell Lines by Regulating Sub Cellular Localization of P21Gastroenterology & Hepatology: Open Access 2015; 3(3) doi: 10.15406/ghoa.2015.03.00079
22
Gang Li, Xin Li, Iqbal Mahmud, Jazmin Ysaguirre, Baharan Fekry, Shuyue Wang, Bo Wei, Kristin L. Eckel-Mahan, Philip L. Lorenzi, Richard Lehner, Kai Sun. Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapyJCI Insight 2023; 8(2) doi: 10.1172/jci.insight.163624
23
Qunying Zhuang, Tengjian Zhou, Chengyong He, Shili Zhang, Yang Qiu, Bing Luo, Ran Zhao, Hengchuan Liu, Yuchun Lin, Zhongning Lin. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133bJournal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0341-z
24
Masanori Ozaki, Ken Kageyama, Kenjiro Kimura, Shinpei Eguchi, Akira Yamamoto, Ryota Tanaka, Takehito Nota, Hiroki Yonezawa, Hideyuki Nishiofuku, Yuki Sakai, Naoki Tani, Atsushi Jogo, Mizue Terai, Takami Sato, Takeaki Ishizawa, Yukio Miki. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinomaScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-61142-y
25
Enas E. Eltamany, Sameh S. Elhady, Mohamed S. Nafie, Haidy A. Ahmed, Dina M. Abo-Elmatty, Safwat A. Ahmed, Jihan M. Badr, Asmaa R. Abdel-Hamed. The Antioxidant Carrichtera annua DC. Ethanolic Extract Counteracts Cisplatin Triggered Hepatic and Renal ToxicitiesAntioxidants 2021; 10(6): 825 doi: 10.3390/antiox10060825
26
Fotini Papachristou, Nikolia Anninou, Georgios Koukoulis, Stefanos Paraskakis, Eleni Sertaridou, Christos Tsalikidis, Michael Pitiakoudis, Constantinos Simopoulos, Alexandra Tsaroucha. Differential effects of cisplatin combined with the flavonoid apigenin on HepG2, Hep3B, and Huh7 liver cancer cell linesMutation Research/Genetic Toxicology and Environmental Mutagenesis 2021; 866: 503352 doi: 10.1016/j.mrgentox.2021.503352
27
Liang-Tzung Lin, Chen-Jei Tai, Ching-Hua Su, Fang-Mo Chang, Chen-Yen Choong, Chien-Kai Wang, Cheng-Jeng Tai. The Ethanolic Extract ofTaiwanofungus camphoratus(Antrodia camphorata) Induces Cell Cycle Arrest and Enhances Cytotoxicity of Cisplatin and Doxorubicin on Human Hepatocellular Carcinoma CellsBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/415269
28
Hao Zhang, Qiao-Ling Yu, Lin Meng, Hong Huang, Hui Liu, Na Zhang, Na Liu, Jun Yang, Yuan-Zhen Zhang, Qiang Huang. TAZ-regulated expression of IL-8 is involved in chemoresistance of hepatocellular carcinoma cellsArchives of Biochemistry and Biophysics 2020; 693: 108571 doi: 10.1016/j.abb.2020.108571
29
Dipak D. Meshram, Claire V.S. Pike, Peter J. Coussons. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapyEuropean Journal of Pharmacology 2017; 815: 332 doi: 10.1016/j.ejphar.2017.09.035
30
Dandan Zhao, Hongyan Zhen, Jian Xue, Zhipeng Tang, Xiaofang Han, Zhanfen Chen. A novel benzothiazole-based mononuclear platinum(II) complex displaying potent antiproliferative activity in HepG-2 cells via mitochondrial-mediated apoptosisJournal of Inorganic Biochemistry 2024; 251: 112437 doi: 10.1016/j.jinorgbio.2023.112437
31
Kenya Kamimura, Takeshi Suda, Takeshi Yokoo, Hiroteru Kamimura, Tsutomu Kanefuji, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Nobuo Waguri, Satoshi Yamagiwa, Shuji Terai. Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trialBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3320-7
32
Kenya Kamimura, Takeshi Suda, Yasushi Tamura, Masaaki Takamura, Takeshi Yokoo, Masato Igarashi, Hirokazu Kawai, Satoshi Yamagiwa, Minoru Nomoto, Yutaka Aoyagi. Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinomaBMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-127
33
Toru Ishikawa, Kazuo Higuchi, Tomoyuki Kubota, Keiichi Seki, Terasu Honma, Toshiaki Yoshida, Tomoteru Kamimura. Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinomaCancer 2011; 117(17): 4018 doi: 10.1002/cncr.25989